Home Cart 0 Sign in  

[ CAS No. 1357072-61-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1357072-61-7
Chemical Structure| 1357072-61-7
Structure of 1357072-61-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1357072-61-7 ]

Related Doc. of [ 1357072-61-7 ]

Alternatived Products of [ 1357072-61-7 ]

Product Details of [ 1357072-61-7 ]

CAS No. :1357072-61-7 MDL No. :MFCD26960936
Formula : C17H14N8S Boiling Point : -
Linear Structure Formula :- InChI Key :JYXHZDNTBJUJNH-UHFFFAOYSA-N
M.W : 362.41 Pubchem ID :56650915
Synonyms :

Calculated chemistry of [ 1357072-61-7 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 23
Fraction Csp3 : 0.12
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 98.38
TPSA : 104.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.67
Log Po/w (XLOGP3) : 1.76
Log Po/w (WLOGP) : 2.56
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 0.79
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.65
Solubility : 0.0807 mg/ml ; 0.000223 mol/l
Class : Soluble
Log S (Ali) : -3.56
Solubility : 0.0994 mg/ml ; 0.000274 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.91
Solubility : 0.00443 mg/ml ; 0.0000122 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.05

Safety of [ 1357072-61-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1357072-61-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1357072-61-7 ]
  • Downstream synthetic route of [ 1357072-61-7 ]

[ 1357072-61-7 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1022151-55-8 ]
  • [ 1150617-94-9 ]
  • [ 1357072-61-7 ]
YieldReaction ConditionsOperation in experiment
87.2% With caesium carbonate In N,N-dimethyl-formamide at 100℃; for 10 h; Inert atmosphere EXAMPLE 1A
6-(1-Methyl-1H-pyrazol-4-yl)-3-(2-methyl-2H-indazol-5-ylthio)-[1,2,4]triazolo[4,3-b]pyridazine
To a solution of 6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine-3-thiol (50 g, 268 mmol) in DMF (750 mL) is added 5-iodo-2-methyl-2H-indazole (55.5 g, 215.1 mmol), 2-Pyridinecarboxylic Acid (5.5 g, 44.7 mmoles), Copper (I) Iodide (4 g, 21.0 mmoles), and Cesium Carbonate (212.5 g, 652.2 moles).
The mixture is under N2 and stirred at 100° C. for 10 hours.
The reaction mixture is then cooled to room temperature and poured into water (2000 mL).
After stirring at room temperature for 30 min, the mixture is extracted with a mixed solvent (2 L*2, CHCl3/IPA=3/1).
The combined organic layer is then washed four times with mixed solution (25percent NH4OH(aq)/brine=1/4; 800 mL), sat. LiCl(aq) (1 L), sat. brine (1.5 L*2), and dry over Na2SO4.
The organic solution is concentrated under reduced pressure to give a brown crude solid product.
The crude product is triturated with ethyl acetate (800 mL) at room temperature for 3 hours and the pure product is collected by filtration to afford the title compound (68 g, 87.2percent) as a white solid. MS (m/z): 363.0 (M+H).
Reference: [1] Patent: US2012/28984, 2012, A1, . Location in patent: Page/Page column 3-4
  • 2
  • [ 5401-94-5 ]
  • [ 1357072-61-7 ]
Reference: [1] Patent: US2012/28984, 2012, A1,
  • 3
  • [ 943541-20-6 ]
  • [ 1357072-61-7 ]
Reference: [1] Patent: US2012/28984, 2012, A1,
  • 4
  • [ 1022091-74-2 ]
  • [ 1357072-61-7 ]
Reference: [1] Patent: US2012/28984, 2012, A1,
  • 5
  • [ 19335-11-6 ]
  • [ 1357072-61-7 ]
Reference: [1] Patent: US2012/28984, 2012, A1,
Same Skeleton Products
Historical Records